I. Coene

发表

Thorough in silico and in vitro cDNA analysis of 21 putative BRCA1 and BRCA2 splice variants and a complex tandem duplication in BRCA2 allowing the identification of activated cryptic splice donor sites in BRCA2 exon 11

A. Vral, W. Foulkes, L. Forétova, 2018, Human mutation.

BRCA1 and BRCA2 germline mutation spectrum and frequencies in Belgian breast/ovarian cancer families

K. Claes, L. Messiaen, A. Paepe, 2004, British Journal of Cancer.

Pathological splice mutations outside the invariant AG/GT splice sites of BRCA1 exon 5 increase alternative transcript levels in the 5′ end of the BRCA1 gene

J. Vandesompele, K. Dahan, K. Claes, 2002, Oncogene.

Diagnosis of Fanconi Anaemia by ionising radiation- or mitomycin C-induced micronuclei.

A. Vral, J. Slabbert, K. De Leeneer, 2018, DNA repair.

Spectrum and characterisation of BRCA1 and BRCA2 deleterious mutations in high-risk Czech patients with breast and/or ovarian cancer

L. Forétova, M. Navrátilová, K. Claes, 2008, BMC Cancer.

Differentiating pathogenic mutations from polymorphic alterations in the splice sites of BRCA1 and BRCA2

Ludwine Messiaen, Eva Machackova, Anne De Paepe, 2003, Genes, chromosomes & cancer.

Rapid and sensitive detection of BRCA1/2 mutations in a diagnostic setting: comparison of two high-resolution melting platforms.

Anne De Paepe, K. Claes, A. De Paepe, 2008, Clinical chemistry.

BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancer

A. Vral, K. Claes, J. Slabbert, 2015, BMC Cancer.

Genotyping of frequent BRCA1/2 SNPs with unlabeled probes: a supplement to HRMCA mutation scanning, allowing the strong reduction of sequencing burden.

K. Claes, A. De Paepe, B. Poppe, 2009, The Journal of molecular diagnostics : JMD.

Prevalence of BRCA1/2 mutations in sporadic breast/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing

K. Claes, A. Paepe, B. Poppe, 2012, Breast Cancer Research and Treatment.

Identification and characterisation of a founder mutation in the Belgian breast/ovarian cancer population

M. Vos, K. Claes, L. Messiaen, 2000 .

Evaluation of densitometric quantitation of ether phospholipids by high performance thin layer chromatography

P. Sandra, W. Bossche, I. Coene, 1990 .